Assembly Biosciences reported EPS of $2.48, versus the Zacks consensus loss of $0.51 (a beat of $2.99) and compared with a loss of $1.57 a year ago (a year-over-year swing of $4.05). The result represents a material turnaround to profitability and should be positive for the stock given the sizeable miss of expectations by analysts.
Assembly Biosciences reported EPS of $2.48, versus the Zacks consensus loss of $0.51 (a beat of $2.99) and compared with a loss of $1.57 a year ago (a year-over-year swing of $4.05). The result represents a material turnaround to profitability and should be positive for the stock given the sizeable miss of expectations by analysts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
